Background: The Coronavirus disease 2019 (COVID-19) is a transmissible illness produced
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has now quickly expanded since
its outbreak in Wuhan City of Hubei region of China to the other parts of the world. In accordance with
the Centers for Disease Control and Prevention (CDC), the spread of COVID-19 emerges typically human-
to-humans through respiratory droplets within an area of 1-2 meters.
Aims and Objective: In the present perspective, we have discussed some of the measures taken to prevent
and treat the patients suffering from COVID-19, and how to restrict further spread of COVID-19
due to SARS-CoV-2.
Results: The general clinical properties are fever, cough, sore throat, headache, tiredness, myalgia and
difficulty in breathing. Presently no approved treatments for COVID-19, as of now, no pharmaceutical
products have been revealed to be harmless and efficient for the management of COVID-19. Various
anti-viral medicines e.g. ribavirin, lopinavir, and ritonavir have been utilized supported on the familiarity
with SARS and MERS. Many drugs and vaccines are currently being studied in clinical trials, jointly
(Solidarity trial) co-sponsored by the WHO.
Conclusion: The use of a mask by fit people in community areas to guard against respiratory viral disease
is presently recommended by WHO. Patients must be kept in individual rooms, the rooms, surfaces
and equipment should go through standard sanitization, possibly with sodium hypochlorite. Consequently,
apart from restricting this epidemic, efforts should be made to plan wide-ranging procedures to
thwart potential outbreaks of the zoonotic sources.